Alexandria for Pharmaceuticals’ profits soar 71% YoY in 11 months
Updated 7/14/2024 11:05:00 AM
Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries reported a 70.6% year-on-year (YoY) increase in its net profit after tax in the first 11 months of fiscal year (FY) 2023/2024, according to a disclosure on July 14th.
Net profits after tax recorded EGP 206.165 million from July to May, up from EGP 120.876 million in the same period a year earlier.
Meanwhile, revenues surged to EGP 1.735 billion from EGP 1.417 billion.
Alexandria Pharmaceuticals, an affiliated company of Drug Holding Company, is an Egypt-based company engaged in the manufacture, development, and marketing of pharmaceutical, chemical, veterinary and nutritional food products, as well as medical appliances such as adhesive plasters, dental cartridges, medicated adhesive tapes, sterile gauze dressing, and surgical gloves.
Related News
